A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.

Ward, S; Morris, E; Bansback, N; Calvert, N; Crellin, A; Forman, D; Larvin, M; Radstone, D; (2001) A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer. Health technology assessment (Winchester, England), 5 (24). pp. 1-70. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta5240

Share

Download

Filename: FullReport-hta5240.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar